158 related articles for article (PubMed ID: 16166566)
1. Angiotensin-converting enzyme inhibition increases basal vascular tissue plasminogen activator release in women but not in men.
Pretorius M; Luther JM; Murphey LJ; Vaughan DE; Brown NJ
Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2435-40. PubMed ID: 16166566
[TBL] [Abstract][Full Text] [Related]
2. 17Beta-estradiol increases basal but not bradykinin-stimulated release of active t-PA in young postmenopausal women.
Pretorius M; van Guilder GP; Guzman RJ; Luther JM; Brown NJ
Hypertension; 2008 Apr; 51(4):1190-6. PubMed ID: 18259028
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin.
Pretorius M; Rosenbaum D; Vaughan DE; Brown NJ
Circulation; 2003 Feb; 107(4):579-85. PubMed ID: 12566370
[TBL] [Abstract][Full Text] [Related]
4. Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition.
Van Guilder GP; Pretorius M; Luther JM; Byrd JB; Hill K; Gainer JV; Brown NJ
Hypertension; 2008 Feb; 51(2):454-9. PubMed ID: 18180402
[TBL] [Abstract][Full Text] [Related]
5. Influence of oral contraceptive use on endothelial t-PA release in healthy premenopausal women.
Hoetzer GL; Stauffer BL; Greiner JJ; Casas Y; Smith DT; DeSouza CA
Am J Physiol Endocrinol Metab; 2003 Jan; 284(1):E90-5. PubMed ID: 12388132
[TBL] [Abstract][Full Text] [Related]
6. B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure.
Cruden NL; Tse GH; Fox KA; Ludlam CA; Megson I; Newby DE
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):772-7. PubMed ID: 15681300
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibition augments coronary release of tissue plasminogen activator in women but not in men.
Matsumoto T; Takashima H; Nakae I; Yamane T; Hayashi H; Horie M;
Hypertension; 2010 Sep; 56(3):364-8. PubMed ID: 20606106
[TBL] [Abstract][Full Text] [Related]
8. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo.
Lang NN; Gudmundsdóttir IJ; Boon NA; Ludlam CA; Fox KA; Newby DE
J Am Coll Cardiol; 2008 Jul; 52(1):33-9. PubMed ID: 18582632
[TBL] [Abstract][Full Text] [Related]
9. Selective stimulation of tissue-type plasminogen activator (t-PA) in vivo by infusion of bradykinin.
Brown NJ; Nadeau JH; Vaughan DE
Thromb Haemost; 1997 Mar; 77(3):522-5. PubMed ID: 9066005
[TBL] [Abstract][Full Text] [Related]
10. Release of tissue-type plasminogen activator in response to muscarinic receptor stimulation in human forearm.
Jern S; Selin L; Bergbrant A; Jern C
Thromb Haemost; 1994 Oct; 72(4):588-94. PubMed ID: 7878638
[TBL] [Abstract][Full Text] [Related]
11. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
[TBL] [Abstract][Full Text] [Related]
12. Vascular B1 kinin receptors in patients with congestive heart failure.
Lang NN; Cruden NL; Tse GH; Bloomfield P; Ludlam CA; Fox KA; Newby DE
J Cardiovasc Pharmacol; 2008 Nov; 52(5):438-44. PubMed ID: 19033823
[TBL] [Abstract][Full Text] [Related]
13. Preserved tissue-type plasminogen activator release and endothelium-dependent vasodilation in postmenopausal women with NIDDM.
Manhem K; Dotevall A; Wilhelmsen L; Jern S
J Diabetes Complications; 2000; 14(3):127-34. PubMed ID: 10989320
[TBL] [Abstract][Full Text] [Related]
14. Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature.
Stein CM; Brown N; Vaughan DE; Lang CC; Wood AJ
J Am Coll Cardiol; 1998 Jul; 32(1):117-22. PubMed ID: 9669258
[TBL] [Abstract][Full Text] [Related]
15. Sympathoadrenal activation and muscarinic receptor stimulation induce acute release of tissue-type plasminogen activator but not von Willebrand factor across the human forearm.
Jern C; Selin L; Tengborn L; Jern S
Thromb Haemost; 1997 Aug; 78(2):887-91. PubMed ID: 9268190
[TBL] [Abstract][Full Text] [Related]
16. Bradykinin receptor antagonism and endothelial tissue plasminogen activator release in humans.
Witherow FN; Dawson P; Ludlam CA; Webb DJ; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1667-70. PubMed ID: 12869356
[TBL] [Abstract][Full Text] [Related]
17. Endogenous nitric oxide contributes to bradykinin-stimulated glucose uptake but attenuates vascular tissue-type plasminogen activator release.
Pretorius M; Brown NJ
J Pharmacol Exp Ther; 2010 Jan; 332(1):291-7. PubMed ID: 19841473
[TBL] [Abstract][Full Text] [Related]
18. Influence of abdominal obesity on vascular endothelial function in overweight/obese adult men.
Weil BR; Stauffer BL; Mestek ML; DeSouza CA
Obesity (Silver Spring); 2011 Sep; 19(9):1742-6. PubMed ID: 21738236
[TBL] [Abstract][Full Text] [Related]
19. Smoking impairs bradykinin-stimulated t-PA release.
Pretorius M; Rosenbaum DA; Lefebvre J; Vaughan DE; Brown NJ
Hypertension; 2002 Mar; 39(3):767-71. PubMed ID: 11897760
[TBL] [Abstract][Full Text] [Related]
20. In vivo release of tissue-type plasminogen activator across the human forearm during mental stress.
Jern C; Selin L; Jern S
Thromb Haemost; 1994 Aug; 72(2):285-91. PubMed ID: 7831666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
